Archery deer season starts statewide Saturday, and bowhunters are excited about embarking on the nation's longest continuous ...
Walk back tuning ensures that your bow with stack arrows on the same vertical plane from 5 yards to as far as you care to shoot. Here's how it's done. In the last installment of this series, we got ...
The cast members of the film New Happy Dad and Son 5: My Alien Friend, the latest installment of the Big-Head Son and Small-Head Dad series, pose at the opening ceremony of the 12th Beijing ...
Contrary to some stereotypes, the involvement of men in child raising and home life is crucial, according to at least one expert. Linda Nielsen is a professor of adolescent and educational psychology ...
The Springboks are confident despite the All Blacks’ undefeated streak at Eden Park. The Rugby Championship clash is hotly anticipated, both rugby heavyweights having shown vulnerability with a loss ...
What if I told you you could have a compound bow that shoots over 320 fps, has several flagship features, shoots tight groups at 50 yards, and costs less than $600? You’d say I’m crazy, right? Meet ...
This is read by an automated voice. Please report any issues or inconsistencies here. A pattern of intentional attacks on wild donkeys in Riverside County began in June, according to authorities. At ...
US central bank's next policy meeting is on September 16-17 Futures contracts point to 10% chance of half-percentage-point rate cut Fed's benchmark interest rate could drop to 3.25%-3.50% by January ...
Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...
After not picking up a third quarterback following the roster cutdown deadline last week, the Detroit Lions finally filled that spot on Thursday, officially signing veteran quarterback C.J. Beathard ...
President Prabowo Subianto of Indonesia acknowledged the concerns of the protesters and said his government would make concessions. By Muktita Suhartono and Sui-Lee Wee Muktita Suhartono reported from ...
Johnson & Johnson has reported new phase 3 data with its FcRn blocker nipocalimab in generalised myasthenia gravis (gMG), pointing to data that it says differentiates it from other drugs in the class.